The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in patients with Merkel cell carcinoma and lymph node metastases.
 
Shailender Bhatia
Honoraria - Bristol-Myers Squibb; Immunocore; Replimune
Consulting or Advisory Role - Bristol Myers Squibb; Immunocore; Replimune
Research Funding - Agenus (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); Incyte (Inst); Merck (Inst); TriSalus Life Sciences (Inst); Tuhura
Travel, Accommodations, Expenses - Regeneron
 
Ted Gooley
Consulting or Advisory Role - Regimmune
 
Andrew Brohl
Consulting or Advisory Role - Deciphera
Research Funding - Merck (Inst)
 
Leslie Fecher
Consulting or Advisory Role - Elsevier; Hoosier Cancer Research Network; Via Oncology
Research Funding - Bristol-Myers Squibb (Inst); Immatics (Inst); Jazz Pharmaceuticals (Inst); Kartos Therapeutics (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Pfizer/Array (Inst); Pfizer/EMD Serono (Inst); Regeneron (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - AIM at Melanoma; AIM at Melanoma; AIM at Melanoma Foundation; AIM at Melanoma Foundation; NCCN
Other Relationship - Pfizer/Array
(OPTIONAL) Uncompensated Relationships - American Association of Clinical Endocrinology; ASCO; NCCN
 
Sunandana Chandra
Honoraria - Bristol Myers Squibb; Immunocore; Merck; Novartis; Pfizer; Regeneron; Replimune; Sanofi/Regeneron
Consulting or Advisory Role - Alkermes; Bristol-Myers Squibb; Celltrion; Immunocore; Novartis; Pfizer; Replimune; Sanofi/Regeneron; Sun Pharma
Research Funding - Bristol Myers Squibb Foundation (Inst); exicure (Inst); Immunocore (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Replimune (Inst); Sanofi/Regeneron (Inst); Werewolf Therapeutics (Inst)
 
Ling Gao
No Relationships to Disclose
 
Ann Silk
Stock and Other Ownership Interests - gral; Illumina
Consulting or Advisory Role - Immunocore; Merck; Regeneron; Sun Pharma; Teva
Research Funding - Checkmate Pharmaceuticals (Inst); Marengo Therapeutics (Inst); Merck (Inst); Natera (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Theresa Medina
Research Funding - Agenus (Inst); Bristol-Myers Squibb (Inst); Day One Biopharmaceuticals (Inst); Genentech (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); TriSalus Life Sciences (Inst); Ultimovacs (Inst)
 
Stergios Moschos
Honoraria - Iovance Biotherapeutics; Skyline Diagnostics
Patents, Royalties, Other Intellectual Property - Joint inventor of Methods and Compositions for the Treatment of Melanoma. U.S. Patent, 63/409.348, PCT/US23/74871
Travel, Accommodations, Expenses - Immatics
 
Wenwen Chen
Stock and Other Ownership Interests - Day One Biopharmaceuticals; Verastem
 
Reina Hibbert
Travel, Accommodations, Expenses - Nektar
 
Sumia Dakhil
No Relationships to Disclose
 
Samantha Kiriluk
No Relationships to Disclose
 
Jenna Voutsinas
No Relationships to Disclose
 
Paul Nghiem
Leadership - Society for Investigative Dermatology (SID)
Honoraria - UpToDate
Consulting or Advisory Role - Almirall
Research Funding - Incyte (Inst)
Patents, Royalties, Other Intellectual Property - Patent filed: "Merkel cell polyomavirus T antigen-specific TCRs and uses thereof" (Inst); Patent pending for high affinity T cell receptors that target the Merkel polyomavirus.
 
Scott Tykodi
Honoraria - Aptitude Health; CancerNetwork; MECC Global Meetings; OncLive/MJH Life Sciences; Targeted Oncology; Topline Bio
Consulting or Advisory Role - Bristol-Myers Squibb; Capvision; FirstWord
Research Funding - AVEO (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); HiberCell (Inst); Merck (Inst); Pfizer (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - DAVA Oncology; KidneyCan
 
Ciara Kelly
Employment - Daichii Sankyo (I)
Stock and Other Ownership Interests - daichii sankyo (I)
Consulting or Advisory Role - Deciphera; Kartos Therapeutics; Natera; SERVIER
Speakers' Bureau - Deciphera
Research Funding - Amgen (Inst); Curadev (Inst); GlaxoSmithKline; IDRx (Inst); InhibRx (Inst); Kartos Therapeutics (Inst); Merck (Inst); Regeneron (Inst); Servier (Inst); xencor (Inst)
Travel, Accommodations, Expenses - Deciphera